Pinar Demirtepe: Not All “Blood Thinners” Are the Same
Pinar Demirtepe, Intensive Care Nurse at Ministry of Health of the Republic of Türkiye, shared a post on LInkedIn:
“One of the things I learned after starting to work in the Coronary Intensive Care Unit surprised me.
Many people, including healthcare professionals early in their careers, use the term ‘blood thinner’ for different medications. However, anticoagulants and antiplatelet drugs are not the same.
Anticoagulants mainly target the coagulation cascade and help prevent fibrin-rich clots, while antiplatelet drugs reduce platelet aggregation and are particularly important in arterial thrombosis, such as coronary artery disease.
Understanding the mechanism behind these medications is far more valuable than simply memorizing their names.
Every day in critical care reminds me how much there is still to learn—and that’s one of the things I enjoy most about this profession.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge